Top 47 alternative sites to enspryng-hcp.com
-
enspryng.com
-
tecentriq-hcp.com
-
actemrahcp.com
-
rydapt.com
-
ponvoryhcp.com
-
durysta.com
-
ponvory.com
-
xareltohcp.com
-
rinvoqhcp.com
-
venclextahcp.com
-
nurtec-hcp.com
-
caplytahcp.com
-
alecensa.com
-
abilifymaintenahcp.com
-
durystahcp.com
-
rituxan-hcp.com
-
esbriethcp.com
-
kalydeco.com
-
suboxone.com
-
orkambi.com
-
xofluza-hcp.com
-
pulmozyme.com
-
evrysdi-hcp.com
-
esbriet.com
-
gavreto-hcp.com
-
tecentriq.com
-
evrysdi.com
-
xofluza.com
-
herceptin.com
-
erivedge.com
-
ocrevus.com
-
rituxanhycela.com
-
cellcept.com
-
tamiflu.com
-
rozlytrek.com
-
gavreto.com
-
gazyva-hcp.com
-
screenyourlungs.org
-
strokeawareness.com
-
gazyva.com
-
rituxan.com
-
hemlibra.com
-
huntingtonsdisease.com
-
genentech-forum.com
-
genentech-pro.com
-
genentechoncology.com
-
genentechhemophilia.com
ENSPRYNG™ (satralizumab) | Neuromyelitis Optica Spectrum Disorder (NMOSD) Treatment
Learn about ENSPRYNG™ (satralizumab), a self-administered, monthly treatment for Neuromyelitis Optica Spectrum Disorder (NMOSD). See full safety for more information.
TECENTRIQ® (atezolizumab) HCP | Efficacy, Safety, PI & MOA
Information for healthcare professionals about the safety, efficacy, dosing, prescribing information and mechanism of action for TECENTRIQ® (atezolizumab). See full safety for additional information.
IMPORTANT SAFETY INFORMATION
HCP info about ACTEMRA® (tocilizumab) treatment for SJIA, PJIA, GCA, SSc-ILD, & RA patients. See Full Safety and Boxed Warnings for more information.
RYDAPT® (midostaurin) Capsules | AML & ASM Treatment
Official HCP website for RYDAPT® (midostaurin). Find indication, treatment, MOA & full safety information here.
The Official HCP Website for PONVORY™ | PONVORY™ (ponesimod) HCP
PONVORY™ (ponesimod) Official Healthcare Professional Website. See full Prescribing & Safety Information.
DURYSTA™ (bimatoprost implant) | Patient Website
Welcome to the website for DURYSTA™ (bimatoprost implant). Please see Important Safety Information and full Prescribing Information.
PONVORY™ (ponesimod) | Official Patient Website
PONVORY™ (ponesimod) Official Patient Website. See full Prescribing & Safety Information.
XARELTO® (rivaroxaban) Information for Healthcare Professionals
XARELTO® is a treatment indicated for patients with NVAF, DVT/PE, or chronic CAD/PAD. See full Safety & Prescribing Info, with Boxed WARNINGS.
RINVOQ™ (upadacitinib) | For Healthcare Professionals
RINVOQ™ is indicated for the treatment of moderate to severe rheumatoid arthritis (RA) in adult MTX-IR patients. Download the RINVOQ Complete Enrollment and Prescription Form. See Important Safety Info, including BOXED WARNING.
Explore phase 3 data for CLL & AML
Select a VENCLEXTA® (venetoclax tablets) indication. VENCLEXTA is an **** therapy for AML, CLL and SLL patients. See full safety for more information.
Nurtec® ODT (rimegepant) | For Healthcare Professionals
Nurtec® ODT (rimegepant) is indicated for the acute treatment of migraine and the preventive treatment of episodic migraine in adults. See safety & efficacy data and view full Prescribing Information.
CAPLYTA® (lumateperone) | Healthcare Professionals
Learn about CAPLYTA, indicated for the treatment of schizophrenia in adults. See efficacy, safety, dosing, pharmacology and savings information. Please see full Prescribing Information, including Boxed Warning.
ALECENSA® (alectinib) and Information for Patients
Find information for patients about treatment with ALECENSA® (alectinib). See full safety for more information.
Schizophrenia Treatment & Bipolar I Maintenance | ABILIFY MAINTENA® (aripiprazole)
ABILIFY MAINTENA® (aripiprazole) is indicated for the treatment of schizophrenia and for Bipolar I maintenance monotherapy in adults. See full Safety and Prescribing Information, including BOXED WARNING.
DURYSTA™ (bimatoprost implant) for Intracameral Administration | HCP Site
Learn about DURYSTA™ (bimatoprost implant), a biodegradable, intracameral implant. Please see Important Safety Information and full Prescribing Information.
Treatment for RA, NHL, CLL, GPA, MPA and PV | RITUXAN® (rituximab)
HCP info about RITUXAN® (rituximab) treatment for RA, NHL, CLL, GPA, MPA and PV including indications, dosing, efficacy and support. Please see Important Safety Information including Boxed Warning and Full Prescribing Information for more information.
Esbriet® (pirfenidone) Information for Healthcare Professionals
Learn about Esbriet® (pirfenidone) as a possible treatment option for IPF, a progressive and irreversible fibrotic interstitial lung disease. See full safety for more information.
KALYDECO® (ivacaftor) | Patient Information
Learn about treatment with KALYDECO, including how to take it, how it works, study results, and possible side effects. Download educational resources. See Important Safety Information and full Prescribing Information.
Patient Information for SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII)
Product details on treatment with SUBOXONE Film, including available savings if eligible, and support sign-up. Search to find a doctor, nurse practitioner or physician assistant waivered to provide opioid dependence treatment in an office setting. See full safety and prescribing information.
Other sites like enspryng-hcp com
ORKAMBI® (lumacaftor/ivacaftor) | Patient Information
Product details on treatment with ORKAMBI, including how to take it, how it works, study results, and possible side effects. Watch videos of patients, get recipes, and download educational resources. Sign up to receive email updates. See Important Safety Information and full Prescribing Information.
Some websites with similar theme to enspryng-hcp.com include:
Single-dose Flu Antiviral | XOFLUZA® (baloxavir marboxil) HCP
Find information for HCPs about XOFLUZA® (baloxavir marboxil), a single-dose **** antiviral treatment for influenza. See full safety for more information.
Cystic Fibrosis Treatment Option | Pulmozyme® (dornase alfa)
Pulmozyme® (dornase alfa) is a nebulized cystic fibrosis (CF) treatment option to help manage CF symptoms. See full safety for more information.
Evrysdi®️ (risdiplam) | Approved Pediatric & Adult SMA treatment
Evrysdi®️ (risdiplam) is a treatment for spinal muscular atrophy (SMA) in patients 2 months of age and older. See full safety for more information.
Idiopathic Pulmonary Fibrosis (IPF) Treatment | Esbriet® (pirfenidone)
Learn about Esbriet® (pirfenidone), a medication for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and irreversible fibrotic interstitial lung disease. See full safety for more information.
GAVRETO® (pralsetinib) for RET+ mNSCLC & Advanced Thyroid Cancer | HCP
Learn about GAVRETO (pralsetinib) for RET+ metastatic NSCLC or advanced thyroid cancer. See important safety for more information.
Cancer Immunotherapy Treatment for NSCLC, ES-SCLC, HCC, Advanced Melanoma & mUC | TECENTRIQ® (atezolizumab)
Learn about TECENTRIQ® (atezolizumab), a cancer Immunotherapy treatment for Non-Small Cell Lung Cancer after surgery and chemo, Metastatic Non-Small Cell Lung Cancer (NSCLC), Extensive-Stage Small Cell Lung Cancer (ES-SCLC), Liver cancer (HCC), Advanced Melanoma & Advanced Bladder Cancer (mUC) | TECENTRIQ® (atezolizumab)
Evrysdi®️ (risdiplam) | Spinal Muscular Atrophy (SMA) Treatment
Evrysdi®️ (risdiplam) is approved to treat spinal muscular atrophy (SMA) in infants, children, & adults 2 months and older. See full safety for more information.
XOFLUZA® (baloxavir marboxil) | Prescription Flu Treatment
Learn about XOFLUZA® (baloxavir marboxil), a one-dose prescription flu treatment that attacks the flu virus at its source. See full safety for more information.
HER2+ Cancer Treatment Option | Herceptin® (trastuzumab)
Find information about Herceptin®, a treatment for Early and Metastatic **** Cancer and Stomach/GEJ Cancer. See full safety & Boxed Warnings for more information.
Erivedge® (vismodegib) | Advanced Basal Cell Carcinoma (aBCC) Treatment
Learn about Erivedge® (vismodegib) as a basal cell carcinoma treatment option for both metastatic and locally advanced carcinoma. See full safety, Boxed Warning, and Medication Guide for more information.
OCREVUS® (ocrelizumab) | Multiple Sclerosis (MS) Treatment
Learn about OCREVUS® (ocrelizumab), a prescription medicine used to treat adults with relapsing or primary progressive multiple sclerosis. See full safety for more information.
RITUXAN HYCELA for FL, DLBCL and CLL
Learn about RITUXAN HYCELA® for subcutaneous injection, a prescription antibody therapy used for FL, DLBCL and CLL. See important safety including Boxed Warnings for more information.
CellCept® (mycophenolate mofetil) | Transplant Rejection Medication
Learn about the CellCept® Co-pay Card and how CellCept (mycophenolate mofetil) is used for people who have had a kidney, heart, or liver transplant. See full safety for more information.
Tamiflu® (oseltamivir phosphate) | Prescription Flu Treatment
Tamiflu® (oseltamivir phosphate) is an antiviral medicine for treatment of flu in people 2 weeks of age and older and for prevention of flu in people 1 year of age and older. See full safety for more information.
ROZLYTREK (entrectinib) ROS1 & TRK Inhibitor
Learn about ROZLYTREK (entrectinib), a treatment option for ROS1+ mNSCLC and certain NTRK fusion-positive solid tumors. See full safety for more information.
RET+ mNSCLC & Advanced Thyroid Cancer Treatment | GAVRETO® (pralsetinib) Patient
Learn about GAVRETO for RET+ metastatic non-small cell lung cancer (mNSCLC) or advanced thyroid cancer. See important safety for more information.
GAZYVA® (obinutuzumab) Treatment, Indications, Dosing & Safety
ScreenYourLungs.org | Lung Cancer Screening
Surviving lung cancer starts with a scan. Find out how you can get a lung cancer screening today.
**** Information and Resources | **** Awareness
Learn about sudden signs of ****, **** risk factors, and why it is important to act immediately when reponding to a ****.
What else enspryng-hcp.com alternative websites
GAZYVA® (obinutuzumab) Treatment, Indications, Dosing & Safety
Learn about GAZYVA® (obinutuzumab) for first-line, R/R follicular lymphoma & first-line CLL. See important safety including Boxed Warnings for more information.
RITUXAN® (rituximab) Medication for RA, NHL, CLL, GPA, MPA & PV
Find info for patients about RITUXAN® (rituximab) medication for RA, NHL, CLL, GPA, MPA, and PV. See full safety and Boxed Warning for more information.
HEMLIBRA® (emicizumab-kxwh) | Hemophilia A Treatment
Learn about HEMLIBRA® (emicizumab-kxwh), a hemophilia A treatment approved for people with hemophilia A with or without factor VIII inhibitors. See full safety and BOXED WARNING.
Huntington's Together | Sharing Wisdom from the Community
Learn about HD and find inspiration in the experiences, advice, and tips shared by the Huntington's disease community.
Genentech Forum | Managed Care Resources
Find helpful resources for managed care and health system decision-makers from Genentech, including oncology cost containment trends and care management workshops.
Genentech Pro
Find information on Genentech's breakthrough medicines led by innovative science. Genentech is a proud member of the Roche Group.
Cancer Information & Resources | Genentech Oncology
Find cancer information & resources. Explore new research in cancer & learn how Genentech is dedicated to investigating diverse biological pathways & disease targets.
Genentech in Hemophilia | We will continue to deliver on the needs of the hemophilia patient community
With your help, we will continue to deliver on the needs of the hemophilia patient community. That is our commitment to you.
